• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Rac Deprenyl-[d3]

General Information
Catalog: BLP-013127
CAS: 1189731-50-7
Molecular Formula: C13H14D3N
Molecular Weight: 190.30
Chemical Structure
Rac Deprenyl-[d3]
Description Rac Deprenyl-[d3] is a labelled Selegiline. Selegiline is an irreversible MAO-B inhibitor can be used for the treatment of movement disorders due to Parkinson's disease.
Synonyms N-(Methyl-d3),α-methyl-N-2-propyn-1-yl-benzeneethanamine; N-(Methyl-d3),α-methyl-N-2-propynylphenethylamine; dl-Deprenyl-d3; Selegiline-d3
IUPAC Name 1-phenyl-N-prop-2-ynyl-N-(trideuteriomethyl)propan-2-amine
Related CAS 14611-51-9 (unlabelled)
Isomeric SMILES [2H]C([2H])([2H])N(CC#C)C(C)CC1=CC=CC=C1
Canonical SMILES CC(CC1=CC=CC=C1)N(C)CC#C
InChI InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/i3D3
InChI Key MEZLKOACVSPNER-HPRDVNIFSA-N
Purity 99% HPLC
Solubility Soluble in Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
Appearance Clear Yellow to Light Brown Oil
Storage Store at -20°C

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x